Market entry · Fractional leadership

Stop paying four firms to disagree with each other.

One accountable team for your US expansion, covering strategy, entity, compliance and go-to-market, with executives who stay on to run it. The same bench is available fractionally to companies already operating here.

42+Years
combined
27+Of them
in the US
24Projects
delivered
$528M+Combined
project value
The problem

Expansion fails in the gaps between advisors

Most companies assemble a consultancy, a law firm, an accountant and a trade body, then spend the first year translating between them. Nobody owns the outcome.

  • 01Fragmented advisory structures
  • 02Slow decision cycles
  • 03Regulatory uncertainty
  • 04Misalignment across multiple parties
  • 05No real presence in the market
  • 06Inefficient or costly execution
One team, accountable for the result

We combine strategy, execution, compliance and market engagement under a single operator-led team, then stay on the ground once the plan is live.

That is the difference between advice you have to implement and an operation that is already running.

Capabilities

Three ways we work with you

Take one track or all three. Most engagements start with the first and continue into the third.

Track 01

Enter the US

Market sizing, competitive and regulatory diagnosis, entity setup, localization, hiring and channel build, through to a live, compliant, selling operation.

Typically 6 to 12 months
Track 02

Fractional C-suite

An operating or commercial executive inside your team without the full-time hire. Open to international entrants and to US-based companies alike.

See how it works →
Track 03

Commercialize & grow

Positioning, pricing, distribution and revenue programs, run by the same people who built the entry plan rather than handed to a new team.

Ongoing engagement
Sectors

Where our depth actually is

We take work where one of us has held the operating seat. That is a narrower list than most firms publish, and it is the reason the work moves quickly.

Life sciences & biotechDiagnostics · Devices · CDMO

Commercialization, regulatory pathway and launch leadership, drawn from C-suite roles at GE Healthcare and Durin Life Sciences. We have taken products from development through first US revenue and stood up a CDMO from company registration to funded manufacturing site.

TechnologyHardware · Proptech · Platforms

US entity build, channel design and national scale-up, including operating leadership for a property technology business through a period of significant regulatory change, where the model had to be rebuilt without losing margin.

AI & digitalApplied AI · Data products

Positioning, pricing and enterprise go-to-market for teams whose product is well ahead of their commercial function. That gap is the common failure mode for technically strong companies arriving in a market that buys differently than their home one.

Track 02 · Open to US-based companies

Fill the seat without making the hire

A senior operating or commercial executive inside your company, accountable for outcomes rather than advice. You do not have to be a market entry client to use it. This is also how we work with US companies that need sector-deep leadership before they need the org chart.

Explore fractional leadership
  • Fractional CEO Operating
  • Fractional COO Operating
  • Commercial lead Revenue
  • Launch leadership Product
  • Board & investor readiness Capital
In their words

We started collaborating with Kayra Partners recently and they were quickly able to help us understand our clients' needs and challenges.

Robert Dann
Managing Partner, Life Sciences Strategies

We see in Kayra Partners a like-minded team: strategic, globally minded, and execution-driven. We look forward to exploring new opportunities together.

Bertan Yordem
Managing Director, PCF
Get started

Start with an assessment, not a proposal

Tell us the market you are trying to reach or the seat you need filled. We will tell you whether we are the right team for it, including when we are not.